CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia

Clinical trial NCT06892951 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06892951
Sponsor: University Hospital, Tours
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pneumocystis Pneumonia Pneumocystis Jirovecii Infection Pneumocystis Infections

Start date: 2025-06-01
Primary completion: 2026-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.